130 related articles for article (PubMed ID: 35171197)
1. Effect of Transcutaneous Magnetic Stimulation in Patients With Ventricular Tachycardia Storm: A Randomized Clinical Trial.
Markman TM; Pothineni NVK; Zghaib T; Smietana J; McBride D; Amankwah NA; Linn KA; Kumareswaran R; Hyman M; Arkles J; Santangeli P; Schaller RD; Supple GE; Frankel DS; Deo R; Lin D; Riley MP; Epstein AE; Callans DJ; Marchlinski FE; Hamilton R; Nazarian S
JAMA Cardiol; 2022 Apr; 7(4):445-449. PubMed ID: 35171197
[TBL] [Abstract][Full Text] [Related]
2. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
AbdelWahab A; Sapp J
Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
[TBL] [Abstract][Full Text] [Related]
3. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
[TBL] [Abstract][Full Text] [Related]
4. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: A systematic review and meta-analysis of randomized controlled trials.
Santangeli P; Muser D; Maeda S; Filtz A; Zado ES; Frankel DS; Dixit S; Epstein AE; Callans DJ; Marchlinski FE
Heart Rhythm; 2016 Jul; 13(7):1552-9. PubMed ID: 26961297
[TBL] [Abstract][Full Text] [Related]
6. Catheter ablation versus medical therapy for treatment of ventricular tachycardia associated with structural heart disease: Systematic review and meta-analysis of randomized controlled trials and comparison with observational studies.
Anderson RD; Ariyarathna N; Lee G; Virk S; Trivic I; Campbell T; Chow CK; Kalman J; Kumar S
Heart Rhythm; 2019 Oct; 16(10):1484-1491. PubMed ID: 31150816
[TBL] [Abstract][Full Text] [Related]
7. Deep sedation as temporary bridge to definitive treatment of ventricular arrhythmia storm.
Bundgaard JS; Jacobsen PK; Grand J; Lindholm MG; Hassager C; Pehrson S; Kjaergaard J; Bundgaard H
Eur Heart J Acute Cardiovasc Care; 2020 Sep; 9(6):657-664. PubMed ID: 32193944
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic Support in Ventricular Tachycardia Ablation: An International VT Ablation Center Collaborative Group Study.
Turagam MK; Vuddanda V; Atkins D; Santangeli P; Frankel DS; Tung R; Vaseghi M; Sauer WH; Tzou W; Mathuria N; Nakahara S; Dickfeld TM; Bunch TJ; Weiss P; Di Biase L; Tholakanahalli V; Vakil K; Tedrow UB; Stevenson WG; Della Bella P; Shivkumar K; Marchlinski FE; Callans DJ; Natale A; Reddy M; Lakkireddy D
JACC Clin Electrophysiol; 2017 Dec; 3(13):1534-1543. PubMed ID: 29759835
[TBL] [Abstract][Full Text] [Related]
9. Neuromodulation for the Treatment of Refractory Ventricular Arrhythmias.
Markman TM; Gugger D; Arkles J; Riley MP; Dixit S; Guandalini GS; Frankel DS; Epstein AE; Callans DJ; Singhal S; Marchlinski FE; Nazarian S
JACC Clin Electrophysiol; 2023 Feb; 9(2):161-169. PubMed ID: 36858681
[TBL] [Abstract][Full Text] [Related]
10. Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.
Siontis KC; Santangeli P; Muser D; Marchlinski FE; Zeppenfeld K; Hoogendoorn JC; Narasimhan C; Sauer WH; Zipse MM; Kapa S; Vedantham V; Rosenthal DG; Robinson MR; Patton KK; Murgatroyd F; Chicos AB; Soejima K; Roukoz H; Sacher F; Bhan A; Appelbaum J; Dickfeld T; Mankad P; Ellenbogen KA; Kron J; Kim HM; Froehlich J; Eagle KA; Bogun FM; Crawford TC
JAMA Cardiol; 2022 Feb; 7(2):175-183. PubMed ID: 34787643
[TBL] [Abstract][Full Text] [Related]
11. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
[TBL] [Abstract][Full Text] [Related]
12. Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial.
Deyell MW; Doucette S; Parkash R; Nault I; Gula L; Gray C; Gardner M; Sterns LD; Healey JS; Essebag V; Sapp JL
Europace; 2022 Jul; 24(7):1112-1118. PubMed ID: 35030257
[TBL] [Abstract][Full Text] [Related]
13. Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Sapp JL; Wells GA; Parkash R; Stevenson WG; Blier L; Sarrazin JF; Thibault B; Rivard L; Gula L; Leong-Sit P; Essebag V; Nery PB; Tung SK; Raymond JM; Sterns LD; Veenhuyzen GD; Healey JS; Redfearn D; Roux JF; Tang AS
N Engl J Med; 2016 Jul; 375(2):111-21. PubMed ID: 27149033
[TBL] [Abstract][Full Text] [Related]
14. Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia.
Robinson CG; Samson PP; Moore KMS; Hugo GD; Knutson N; Mutic S; Goddu SM; Lang A; Cooper DH; Faddis M; Noheria A; Smith TW; Woodard PK; Gropler RJ; Hallahan DE; Rudy Y; Cuculich PS
Circulation; 2019 Jan; 139(3):313-321. PubMed ID: 30586734
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy.
Kottkamp H; Hindricks G; Chen X; Brunn J; Willems S; Haverkamp W; Block M; Breithardt G; Borggrefe M
Circulation; 1995 Sep; 92(5):1159-68. PubMed ID: 7648661
[TBL] [Abstract][Full Text] [Related]
17. Antiarrhythmic Drugs for Nonshockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The ALPS Study (Amiodarone, Lidocaine, or Placebo).
Kudenchuk PJ; Leroux BG; Daya M; Rea T; Vaillancourt C; Morrison LJ; Callaway CW; Christenson J; Ornato JP; Dunford JV; Wittwer L; Weisfeldt ML; Aufderheide TP; Vilke GM; Idris AH; Stiell IG; Colella MR; Kayea T; Egan D; Desvigne-Nickens P; Gray P; Gray R; Straight R; Dorian P;
Circulation; 2017 Nov; 136(22):2119-2131. PubMed ID: 28904070
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Noninducibility on Outcomes of Ventricular Tachycardia Ablation: A VANISH Substudy.
Essebag V; Joza J; Nery PB; Doucette S; Nault I; Rivard L; Gula L; Deyell M; Raymond JM; Lane C; Sapp JL
JACC Clin Electrophysiol; 2018 Jul; 4(7):911-919. PubMed ID: 30025692
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268
[TBL] [Abstract][Full Text] [Related]
20. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial.
Raitt MH; Connor WE; Morris C; Kron J; Halperin B; Chugh SS; McClelland J; Cook J; MacMurdy K; Swenson R; Connor SL; Gerhard G; Kraemer DF; Oseran D; Marchant C; Calhoun D; Shnider R; McAnulty J
JAMA; 2005 Jun; 293(23):2884-91. PubMed ID: 15956633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
